1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Intellinews - Romania Pharmaceutical Report - August 2013

Intellinews - Romania Pharmaceutical Report - August 2013

  • September 2013
  • -
  • Emerging Markets Direct Media Holdings
  • -
  • 15 pages

Summary

Table of Contents

Search Inside

The Romanian pharmaceutical market increased by 2.7% y/y (3.4% y/y in EUR terms) to RON 2.8bn (EUR 647.5mn) in Q2/2013, tempering from the 4.3% y/y growth in the previous quarter. On a quarterly basis, the market shrank both in local currency and EUR terms, as it continued to be negatively affected by the drawback of public support and long payment terms.

Prospects for H2/2013 remain rather on the pessimistic side, considering the authorities’ delay in revising the subsidized drug list and the budget constraints affecting the sales through hospitals. Market forecasts see the full-year growth at around 0.7% y/y in RON terms, slowing down abruptly from the 8.3% y/y rise in 2012.

The OTC segment continued to perform above the market average in Q2, as pharmaceutical companies have been paying increasing attention to their OTC portfolios since the introduction of the clawback tax in 2012. The share of OTC in total pharma sales rose by 0.7pps in Q2/2013 compared to the same quarter in 2012, but the bulk of sales continued to be generated by prescription-based medicines.

Pharmacy chains kept cautious expansion policy in H1/2013, yet larger players announced ambitious development plans for the following years. According to the latest statistical data released in July this year, the number of pharmacies increased by 2% y/y in 2012 and, considering the openings announced by the biggest chains, roughly the same growth pace will be maintained in 2013 as well.

The ranking of the top pharmaceutical chains remained unchanged in 2012 compared to 2011, in terms of revenues. The cumulated net turnover of the top five players increased by 9.4% y/y in 2012, according to our calculations based on official financial data published in July 2013. In terms of net profit, two of the largest five players turned to net loss last year, compared to 2011 when all the biggest pharmacy chains reported net profit. However, this is mostly explained by the chains’ continuous expansion- with one exception, all the top five players reported increasing headcount in 2012 compared to 2011.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • April 2017
    44 pages
  • Therapy  

    Serotonin Speci...  

    Antidepressant  

  • United States  

View report >

Stroke Statistics in the US

  • April 2017
    4 pages
  • Stroke  

    Blood Disease  

  • United States  

View report >

Anti-Infective Market in the Netherlands and Germany

  • April 2017
    10 pages
  • Anti-Infective  

  • Netherlands  

    Germany  

    Europe  

View report >

Related Market Segments :

Pharmaceutical

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.